⌘K

Home/Filings/4/0001213900-20-007845

4//SEC Filing

Newman James W. Jr. 4

Accession 0001213900-20-007845

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 9:23 AM ET

Size

10.8 KB

Accession

0001213900-20-007845

Insider Transaction Report

Form 4

Period: 2020-03-27

ADIAL PHARMACEUTICALS, INC.ADIL

Newman James W. Jr.

Director

Transactions

Purchase
Common Stock
2020-03-27$1.42/sh+5,000$7,100→ 15,000 total
Purchase
Common Stock
2020-03-27$1.34/sh+10,000$13,400→ 13,288 total(indirect: By Partnership)
Purchase
Common Stock
2020-03-27$1.35/sh+4,644$6,269→ 14,644 total(indirect: By IRA)

Holdings

Common Stock
(indirect: By LLC)
150,419
Common Stock
(indirect: By LLC)
35,221
Common Stock
(indirect: By Trust)
41,160

Footnotes (5)

[F1]James W. Newman is the general partner of Roundtop Limited Partnership, LLP.
[F2]James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr.
[F3]James W. Newman is the sole member of Virga Ventures, LLC.
[F4]James W. Newman is the general partner of Ivy Cottage Group, LLC.
[F5]James W. Newman is the beneficiary of this Roth IRA.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718364

Filing Metadata

Form type: 4
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 9:23 AM ET
Size: 10.8 KB

View on SEC.gov